Global BioAccess Fund partners with companies to invest in transformative technologies addressing unmet needs in oncology, cardiovascular, CNS, and rare diseases. The fund invests in companies developing novel therapeutics and devices for serious unmet medical needs, focusing on early-stage companies needing capital for IND submission and clinical trials.

Global BioAccess Fund

At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.

Congratulations to Acesion Pharma on their publication in Nature Medicine and launching their Ph 1 trial!

We look forward to working with the Odyssey team and Board as they move multiple programs into the clinic.
https://lnkd.in/eWzTVQxh

We are thrilled to be working with Acesion Pharma, Canaan, Alpha Wave Global, LP and Novo Holdings to bring safer and more effective treatments to patients with atrial fibrillation.

https://lnkd.in/e2XDz4zX

GLOB

COM:GLOBALBIOACCESS

Global BioAccess Fund

name

homepage url

country

linkedin url

employee count

sector

industry

monthly webtraffic

Description

invested in

Metrics